1. Home
  2. MDXG vs VYX Comparison

MDXG vs VYX Comparison

Compare MDXG & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • VYX
  • Stock Information
  • Founded
  • MDXG 2006
  • VYX 1881
  • Country
  • MDXG United States
  • VYX United States
  • Employees
  • MDXG N/A
  • VYX N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • VYX
  • Sector
  • MDXG Health Care
  • VYX
  • Exchange
  • MDXG Nasdaq
  • VYX Nasdaq
  • Market Cap
  • MDXG 1.0B
  • VYX 1.2B
  • IPO Year
  • MDXG N/A
  • VYX N/A
  • Fundamental
  • Price
  • MDXG $7.25
  • VYX $11.10
  • Analyst Decision
  • MDXG Strong Buy
  • VYX Strong Buy
  • Analyst Count
  • MDXG 3
  • VYX 6
  • Target Price
  • MDXG $12.00
  • VYX $14.83
  • AVG Volume (30 Days)
  • MDXG 815.1K
  • VYX 2.0M
  • Earning Date
  • MDXG 04-30-2025
  • VYX 05-08-2025
  • Dividend Yield
  • MDXG N/A
  • VYX N/A
  • EPS Growth
  • MDXG N/A
  • VYX N/A
  • EPS
  • MDXG 0.27
  • VYX 6.72
  • Revenue
  • MDXG $352,375,000.00
  • VYX $2,733,000,000.00
  • Revenue This Year
  • MDXG $9.23
  • VYX N/A
  • Revenue Next Year
  • MDXG $11.49
  • VYX N/A
  • P/E Ratio
  • MDXG $26.71
  • VYX $1.58
  • Revenue Growth
  • MDXG 5.34
  • VYX N/A
  • 52 Week Low
  • MDXG $5.47
  • VYX $7.55
  • 52 Week High
  • MDXG $10.14
  • VYX $15.34
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 54.99
  • VYX 74.07
  • Support Level
  • MDXG $6.53
  • VYX $8.55
  • Resistance Level
  • MDXG $7.52
  • VYX $9.05
  • Average True Range (ATR)
  • MDXG 0.34
  • VYX 0.35
  • MACD
  • MDXG 0.11
  • VYX 0.35
  • Stochastic Oscillator
  • MDXG 81.63
  • VYX 94.27

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

Share on Social Networks: